View Document Preview and Link Document Date: 2014-10-27 18:24:22 Open Document File Size: 2,20 MB Share Result on Facebook
City Cambridge / Waltham / / Company MZ KF AG / IMS Health Incorporated / Vertex Pharmaceuticals Incorporated. / Bernstein / Brodin HF / Trinity Partners LLC / Creative Commons / Microsoft / / Continent Europe / / Country United States / / Currency USD / / / Event FDA Phase / / Facility American Managed Care Pharmacy / / IndustryTerm reagents/materials/ analysis tools / prevention of hepatitis C / direct healthcare cost / conference travel grants / treatment of HCV / healthcare system / care for HCV / carrier data / HCV treatment / healthcare costs / for-profit healthcare consultancy / treatment for HCV / / MedicalCondition advanced disease / HCV patient disease / TB / JE / total hepatitis C / HCV-related cirrhosis / alcohol abuse / HCV-infected patient disease / cirrhosis / transfusion-related infection / hepatitis C / faster fibrosis / each HCV disease / another HCV-related disease / HCV genotype 3 / Increased fibrosis / Liver cirrhosis / period hepatitis-C infection / end-stage renal disease / US chronic HCV / chronic HCV infection / different disease / MS / HCV infections / liver disease / United States of America Abstract Chronic hepatitis C / hepatic fibrosis / hepatitis C. Hepatology / diagnosed chronic HCV / human immunodeficiency virus infections / cancer / previously untreated chronic hepatitis C / disease / Decompensated cirrhosis / hepatocellular carcinoma / Cirrhosis* Liver Cancer Liver Transplant Liver Cancer / chronic liver disease / liver diseases / future hepatitis C / chronic HCV / diabetes / hepatic encephalopathy / HCV / annual chronic HCV / HCV infection / initial infection / virus infection / US HCV disease / portal hypertension / liver cancer / namely cirrhosis / Cirrhosis N/A / advanced fibrosis / accelerated fibrosis / infection / high infectious risk donors / viral hepatitis / advanced liver disease / HCV disease / each HCV-related disease / HCV-related disease / latent disease / chronic hepatitis C / HCV RNA / / MedicalTreatment Liver Transplant / antiviral therapy / Liver transplants / / Organization Center for Disease Control / Centers for Disease Control and Prevention / Medicare / US Census Bureau / National Center for HIV/AIDS / US Medicare / Department of Health and Human Services / / Person Ann Int Med / Yury E. Khudyakov / C. Ann Int Med / Mrudula Donepudi / Kristin Stephan / C. Ann Intern Med / C. Arch Intern Med / Baris Deniz / / Position driver / original author / Editor / physician / Chronic HCV Population Disease Progression Acknowledgments Author / / Product peginterferon / ribavirin / HCVinfected injection / HCV / / ProvinceOrState Massachusetts / / PublishedMedium PLoS ONE / Morbidity and Mortality Weekly Report / the PLOS ONE / / RadioStation Di Bisceglie AM / / TVStation Kyle / / Technology alpha / relational database / transplantation / html / genotype / / URL http / SocialTag 
Current and Future Disease Progression of the Chronic HCV Population in the United States Martin Zalesak1*, Kevin Francis1, Alex Gedeon1, John Gillis1, Kyle Hvidsten2, Phyllis Kidder2, Hong Li1, Derek Martyn1, Leslie Orn